BLEXIT - best perioperative outcomes from cystectomy
Poster Session 20
-
Location:Room Copenhagen, North Hall (Level 1)
-
Chairs:
-
Aims and objectives of this session To understand how to optimize perioperative outcomes in cystectomy.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
Institutes: 1Nara Medical University, Dept. of Urology, Nara, Japan, 2Nara Medical University, Dept. of Radiology, Nara, Japan, 3Nara City Hospital, Dept. of Pathology, Nara, Japan
Institutes: 1Aarhus University Hospital, Skejby, Dept. of Urology, Aarhus N, Denmark, 2Aarhus University Hospital, Skejby, Dept. of Clinical Medicine, Aarhus N, Denmark
Institutes: 1Erasmus MC, Dept. of Pathology, Rotterdam, The Netherlands, 2Erasmus MC, Cancer Computational Biology Center (CCBC), Rotterdam, The Netherlands, 3Erasmus MC, Dept. of Urology, Rotterdam, The Netherlands
Institutes: 1University of Regensburg, Dept. of Urology, Regensburg, Germany, 2General Hospital of Bolzano, Dept. of Urology, Bolzano, Italy, 3Laval University, Dept. of Urology, Québec, Canada
Institutes: 1IRCCS Ospedale San Raffaele, Division of Oncology/Unit of Urology; URI, Milan, Italy, 2Prostate Cancer Center Hamburg-Eppendorf, Martini-Clinic, Hamburg, Germany, 3University of Montreal Health Center, Cancer Prognostics and Health Outcomes Unit, Montreal, Canada, 4Medical University of Vienna, Dept. of Urology, Vienna, Austria, 5University of Montreal Health Center, Dept. of Urology, Montreal, Canada
Institutes: 1TU Dresden, Medical Faculty Carl Gustav Carus, Dept. of Urology, Dresden, Germany, 2TU Dresden, Medical Faculty Carl Gustav Carus, Dept. of Medical Statistics and Biometry, Dresden, Germany
Institutes: 1IRCCS Ospedale San Raffaele, Dept. of Oncology and Urology, Milan, Italy, 2Prostate Cancer Center Hamburg-Eppendorf, Martini-Clinic, Hamburg, Germany, 3University of Montreal Health Center, Cancer Prognostics and Health Outcomes Unit, Montreal, Canada, 4Medical University of Vienna, Dept. of Urology, Vienna, Austria, 5University of Montreal Health Center, Dept. of Cancer Prognostics and Health Outcomes, Montreal, Canada
Institutes: 1University Hospital Schleswig-Holstein, Campus Luebeck, Dept. of Urology, Luebeck, Germany, 2Kurpark-Klinik, Dept. of Urology, Bad Nauheim, Germany, 3Hanover Medical School, Dept. of Urology, Hanover, Germany
Institutes: Isfahan University of Medical Sciences, Dept. of Urology, Isfahan, Iran
Institutes: 1Royal Devon and Exeter Hospital, Dept. of Urology, Exeter, United Kingdom, 2South Tees NHS Trust, Dept. of Urology, Middlesbrough, United Kingdom, 3North Bristol NHS Trust, Dept. of Urology, Bristol, United Kingdom, 4BAUS, Dept. of Surgery, London, United Kingdom, 5Public Health England, Dept. of Public Health, London, United Kingdom
Institutes: 1IRCCS Ospedale San Raffaele, Dept. of Urology, Milan, Italy, 2Magna Graecia University of Catanzaro, Dept. of Urology, Catanzaro, Italy, 3Luzerner Kantonsspital, Dept. of Urology, Lucerne, Switzerland, 4Medical University of Vienna, Dept. of Urology, Vienna, Austria
Institutes: 1Brigham and Women’s Hospital, Harvard Medical School, Division of Urological Surgery and Center For Surgery and Public Health, Boston, United States of America, 2Brigham and Women’s Hospital, Harvard Medical School, Division of Urological Surgery and Center For, Boston, United States of America, 3Henry Ford Health System, VUI Center For Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Detroit, United States of America, 4Pitié-Salpêtrière, APHP, University Paris VI, Dept. of Urology, Paris, France, 5Dana Farber Cancer Institute, Dept. of Medical Oncology, Boston, United States of America, 6Brigham and Women’s Hospital, Harvard Medical School, Dept. of Radiation Oncology, Boston, United States of America